WHO WE ARE
Imperial Bioscience is a biopharmaceutical company committed to developing and commercialising innovative therapeutics to provide life-enhancing treatments. Traditional methods of delivering drug substances (active ingredients) into the human body include orally administered medicines, injections, ointments, and patches. The "dissolving microstructure"; developed, produced, and commercialised by Imperial Bioscience has enhanced the existing drug delivery system, making it not only safer and more convenient but also more efficient in the delivery of active ingredients.
The new delivery system developed by Imperial Bioscience leads to significant change and enhances convenience in people's daily lives. It also helps many people maintain their youth and beauty by delivering active ingredients more effectively than conventional cosmetics as well as more safely and conveniently than hospital procedures and treatments.
This water-resistant backing sticks
firmly to the target area, making sure that the patch stays securely in place.
are gently dissolved within
two hours of application.
Our products are based on natural hyaluronic acid in the form of self-dissolving micro-cones. The microstructure concentrates and precisely delivers the active ingredients to target areas of concern for the improvement of the targeted skin condition.
WHY IT WORKS
The innovative microstructure overcomes the skin diffusion limitations for optimum results that raise the bar for performance and safety.
the skin's top layer
within two hours and
start releasing active
Active ingredients are
delivered directly and
deeply into the skin for
A dissolving microneedle patch is a method that delivers drugs effectively by penetrating the skin with a structure as thin as a mosquito's proboscis. This microneedle patch represents a novel drug delivery system, often referred to as a patch-type painless injection, merging the simplicity of a patch with the efficient drug delivery of an injection
Get the latest updates from Imperial Bioscience on new research, company news and events
"The Best Beauty And Skincare Product To Invest In 2022"
Dr. MUHAMMET AVCIL
Chief Executive Officer
Dr Muhammet Avcil, the CEO of Imperial Bioscience Ltd, stands as a visionary leader at the forefront of scientific innovation in the pharmaceutical industry. With a background in biotechnology and extensive expertise in drug-delivery technologies, Dr Avcil is a globally recognized biomedical scientist and one of the foremost experts in drug delivery. He has played a pivotal role in shaping the company's journey towards revolutionizing healthcare. His unwavering commitment to pushing the boundaries of what's possible, coupled with a passion for research and development, has led Imperial Bioscience to create cutting-edge Microarray Patch (MAP) technology.
Dr Avcil's leadership, combined with his multi award-winning achievements, has not only driven the company's success but has also contributed significantly to advancements in patient-centric solutions. Under his guidance, Imperial Bioscience continues to make remarkable strides in transforming drug delivery methods for improved patient outcomes.
OUR ABSTRACTS & PUBLICATIONS
Microneedles in Drug Delivery:
Progress and Challenges
OCTOBER 28 2021
In recent years, an innovative transdermal delivery technology has attracted great interest for its ability to distribute therapeutics and cosmeceuticals for several applications, including vaccines, drugs, and biomolecules for skin-related problems.